Unlisted Product

Verify with FDA CVM →

15 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
15
Total Reports
1
Deaths Reported
670.0%
Death Rate

Active Ingredients

Unlisted Product

Administration Routes

TopicalUnknown

Species Affected

Dog 10
Cat 3
Unknown 1
Other 1

Most Affected Breeds

Domestic Shorthair 2
Unknown 2
Retriever (unspecified) 2
Spaniel - Cocker American 1
Crossbred Canine/dog 1
Mixed (Dog) 1
Terrier - Jack Russell 1
Terrier - Yorkshire 1
Poodle - Toy 1
Dog (unknown) 1

Most Reported Reactions

Lack of efficacy (ectoparasite) - flea 6
Lack of efficacy - NOS 5
Scratching 3
Vocalisation 2
Behavioural disorder NOS 2
Containers, Damaged 1
Reddening of the skin 1
Diarrhoea 1
Ataxia 1
Panting 1
Alopecia local 1
Biting - pruritus (see also Behavioural disorders) 1

Outcome Breakdown

Outcome Unknown
11 (78.6%)
Recovered/Normal
2 (14.3%)
Died
1 (7.1%)

Data Summary

Metric Value
Total adverse event reports 15
Reports involving death 1
Case-fatality rate (reported events) 670.0%
Distinct species in reports 4
Distinct breeds in reports 12
Distinct reactions reported 18
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Unlisted Product Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 15 adverse event reports referencing Unlisted Product, including 1 reports in which the animal died — a 670.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Unlisted Product. Reported administration routes include Topical, Unknown. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Unlisted Product reports are Dog (10 reports), Cat (3 reports), Unknown (1 reports), with Dog accounting for the largest share. Within those species, Domestic Shorthair (2), Unknown (2), Retriever (unspecified) (2) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Unlisted Product are Lack of efficacy (ectoparasite) - flea (6), Lack of efficacy - NOS (5), Scratching (3), Vocalisation (2). Of the 14 reports with a coded outcome, Outcome Unknown is the leading category at 78.6%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Unlisted Product.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial